Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

I think we will get news of the 2b/3 COVID Trial enrollment next week. I hope the theory of enrollment means dose start in the IPF Trial will be true...GLTA...



Our competition others have posted about are interesting;

Relief (rlf) is repurposing the drug Aviptadil..artcle follows??
https://www.timesofisrael.com/erectile-dysfunction-drug-shows-promise-treating-covid-israeli-innovator-says/

Revive(rvv) has this in the latest PR...

Currently, the Company is exploring the use of Bucillamine for the potential treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. With its recent acquisition of Psilocin Pharma Corp., Revive is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. Revive’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the company was granted FDA orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation. For more information, visit www.ReviveThera.com.